Key Takeaways
- Pfizer (PFE) has signed a landmark drug pricing agreement with the U.S. government, leading to a rise in drugmakers' stocks and offering discounts of up to 85%, averaging 50%, on many primary care and select specialty medications.
- U.S. Trade Representative Jamieson Greer confirmed that President Trump’s tariff structure will maintain August 1 rates, including an average 55% tariff on Chinese imports, and indicated a shift towards bilateral rather than trilateral North American trade negotiations.
- President Trump warned of a probable government shutdown, stating that "irreversible" actions could be taken, while USTR Greer assured that his office would remain fully operative.
- Tesla's (TSLA) stock surged over 30% in September, with investors anticipating strong third-quarter sales figures and rallying around Elon Musk's renewed focus on the carmaker.
- The EEOC has filed a lawsuit against Apple (AAPL) for religious discrimination and retaliation, alleging the company failed to accommodate an employee's Sabbath observance and later terminated him.
U.S. drugmakers saw their stocks rise today after Pfizer (PFE) announced a significant drug pricing deal with the U.S. government. The voluntary agreement aims to lower prescription drug costs for American patients, with Pfizer committing to offer discounts up to 85%, averaging 50%, on many primary care and select specialty medications through a direct purchasing platform, TrumpRx.gov. While specific financial terms remain confidential, the deal provides Pfizer with a three-year grace period from potential Section 232 tariffs, contingent on increased U.S. manufacturing investment. President Trump praised the agreement and noted that Eli Lilly (LLY) drug prices are also dropping significantly, reiterating his threat to impose an additional 5% to 8% tariff on pharmaceutical companies that do not make similar deals. The FDA is also encouraging domestic drug manufacturing through its new "FDA PreCheck" program, offering faster reviews for companies that build U.S. facilities and equalize prices. This initiative, in response to a May executive order, seeks to reduce reliance on foreign drug manufacturing, which currently accounts for over half of pharmaceuticals distributed in the U.S..
On the trade front, U.S. Trade Representative Jamieson Greer confirmed that President Trump’s tariff structure will adhere to August 1 rates, which includes an average 55% tariff on Chinese imports, describing it as the "status quo". Greer indicated a strategic shift, stating that many North American trade talks would be bilateral rather than trilateral, and accused Mexico of not following USMCA rules prior to renegotiation. He also suggested that some tariff revenue should be allocated to support U.S. manufacturers and key industries like shipbuilding. Greer further noted that China's "wolf warrior" attitude is impacting economic ties and that their negotiations have a greater political focus.
Meanwhile, concerns about a potential government shutdown escalated as President Trump warned of its likelihood and the possibility of "irreversible" impacts, including medically related actions and significant federal worker layoffs. Despite a meeting with Democratic leaders Schumer and Jeffries, a breakthrough was not announced. USTR Greer, however, stated that his office would remain fully operational even if the government shuts down.
In other corporate news, Tesla's (TSLA) stock has seen a robust rally, climbing over 30% in September. Investors are keenly awaiting the release of key third-quarter sales figures later this week, with consensus estimates around 447,000 vehicles and some forecasts as high as 495,000. This surge is attributed to renewed investor confidence in Elon Musk's focus on the carmaker and anticipation of strong deliveries, partly due to a rush of purchases before the $7,500 federal EV tax credit expired on September 30.
The EEOC has filed a lawsuit against Apple (AAPL), alleging religious discrimination and retaliation. The lawsuit claims that Apple unlawfully failed to accommodate a long-time employee's Jewish faith by requiring him to work on his Sabbath and subsequently fired him based on his religion. Separately, Federal Communications Commission Chair Brendan Carr denied that the agency is using its power to target critics of President Trump, following accusations of politicization and calls for his resignation. In international developments, Brazil’s antitrust authority, Cade, has suspended a block on the Soy Moratorium until year-end, a decision drawing debate over its impact on environmental protection and competition. Finally, Danske Bank warned of a "risk of bull trap in USD tactical longs" into the September Non-Farm Payrolls (NFP) report.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.